Registration

ZHF CONSULTING LLC for MEDISCA, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2871; opioid issues; drug spending; Drug Quality Security ACT

LobbyistCovered position, as disclosed
STEVE AUSTRIA New U.S. Congress, 2009-2013

Bills named: H.R. 2871 (115th)

Budget/Appropriations BUD

H.R. 2871; opioid issues; drug spending; Drug Quality Security ACT

LobbyistCovered position, as disclosed
STEVE AUSTRIA New U.S. Congress, 2009-2013

Bills named: H.R. 2871 (115th)

Defense DEF

H.R. 2871; opioid issues; drug spending; Drug Quality Security ACT

LobbyistCovered position, as disclosed
STEVE AUSTRIA New U.S. Congress, 2009-2013

Bills named: H.R. 2871 (115th)

Pharmacy PHA

H.R. 2871; opioid issues; drug spending; Drug Quality Security ACT

LobbyistCovered position, as disclosed
STEVE AUSTRIA New U.S. Congress, 2009-2013

Bills named: H.R. 2871 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.